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Abstract 
 
This paper analyses existing trends in the collaborative structure of the Pharmacology and 
Pharmacy field in Spain and explores its relationship with research impact. The evolution in 
terms of size of the research community, the typology of collaborative links (national, 
international) and the scope of the collaboration (size of links, type of partners) are studied by 
means of different measures based on co-authorship. Growing heterogeneity of collaboration 
and impact of research are observed over the years. Average journal impact (MNJS) and citation 
score (MNCS) normalised to world average tend to grow with the number of authors, the number 
of institutions and collaboration type. Both national and international collaboration show MNJS 
values above the country’s average, but only internationally co-authored publications attain 
citation rates above the world’s average. This holds at country and institutional sector levels, 
although not all institutional sectors obtain the same benefit from collaboration. Multilateral 
collaboration with high-level R&D countries yields the highest values of research impact, 
although the impact of collaboration with low-level R&D countries has been optimised over the 
years. Although scientific collaboration is frequently based on individual initiative, policy actions 
are required to promote the more heterogeneous types of collaboration. 
 
Keywords: scientific collaboration, research impact, bilateral and multilateral collaboration, 
Spain, biomedicine, co-authorship. 
 
 
 
Introduction 
 
Science is increasingly becoming a collaborative endeavour. Collaboration allows scientists to 
share knowledge, expertise and techniques, cope with interdisciplinary research topics, and get 
involved in sophisticated research projects (Katz and Martin, 1997). It is responsible for the 
creation of a knowledge flow which interconnects scientists, institutions and countries, 
contributes to determine the cognitive and social structure of scientific fields (Corley et al., 2006), 
and has a great influence on the output of research (Sonnenwald, 2007).  
 
From a bibliometric standpoint, collaboration is usually analysed through co-authorship in 
scientific publications. Many bibliometric studies have analysed the effect of collaboration on the 
productivity and/or impact of publications at the micro level (scientists) (He, 2009), the meso 
level (institutions, disciplines) (Abramo et al., 2009; Franceschet and Costantini, 2010; Gazni 
and Didegah, 2011) and the macro level (countries) (Narin, Stevens and Whitlow, 1991; Glänzel, 
2001). The idea that collaboration is linked to high scientific productivity of scientists has been 
pointed out by some authors (Lee and Bozeman, 2005), while the positive influence of 
collaboration - especially international collaboration- on research impact has been discussed by 
others (Glänzel, 2001).  
 
Collaboration shows a growing trend in intensity, range of aims and heterogeneity (Jha and 
Welch, 2010). The term “heterogeneous collaboration” is used in the literature to refer to 
collaboration which concerns a variety of participants or purposes (Hackett, 2005). Partner 
diversity contributes to boost the benefits of collaboration since it brings about a higher variety of 
points of view leading to higher creativity (Reagans and Zuckerman, 2001) and innovation 
(Talke et al., 2011), and in the long term, to step up the advance of knowledge. Collaboration 
among different institutions is supposed to involve a higher degree of heterogeneity when 
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compared to in-house collaboration and has been associated with higher impact and quality of 
research (Franceschet et al., 2010). 
 
The study of collaboration practices and their relationship with research impact is a matter of 
great concern for policy makers and scientists themselves. Under the assumption that 
collaboration enhances the quality of scientific research and even improves its efficiency and 
effectiveness (Adams, 2005; The Royal Society, 2011) national and supra-national policies have 
been implemented to foster collaboration. However, the study of collaboration should be 
contextualised by country and by field since differences between countries and fields have been 
described in collaborative practices as well as in their tendency to gain from collaboration 
(Glänzel, 2001; Glanzel and Lange, 2002). This study is focused on the Pharmacology and 
Pharmacy field in Spain which is a biomedical research area of strategic interest in the country 
given the existence of a relatively high share of scientific output by private companies.   
 
 
Objectives 
 
The main objective of this paper is to study the evolution over time of the collaborative structure 
of the Pharmacology field in Spain and to explore its relationship with research impact. This 
paper (a) analyses the evolution in terms of size of the research community, the typology of 
collaborative links (national, international) and the scope of the collaboration (size of links, type 
of partners) by means of measures based on co-authorship and (b) explores the relationship 
between collaboration and research impact1. 
 
The following questions are addressed: Are there any changes in collaborative practices over 
time? Does collaboration contribute to increase the productivity of scientists in the field? Does 
the impact of research tend to increase with the heterogeneity of collaboration?  
 
The study of heterogeneity in collaboration is addressed in this paper considering different 
related measures. Heterogeneity is assumed to increase as we move up the collaboration-type 
ladder (from no collaboration to national collaboration and to international collaboration) and with 
the size of links (number of authors, number of institutions, number of countries). The 
relationship between heterogeneity of collaboration and research impact is then explored in this 
framework. The influence of type of partner (by institutional sector, by R&D intensity of countries) 
on the impact of collaborative research is also analysed.  
 
 
Methodology 
 
The scientific output of Spanish authors in journals included in the Pharmacology and Pharmacy 
subfield of the Web of Science database is analysed over two 3-year periods: 1998-2000 and 
2006-2008. Only articles and reviews are studied. The analysis focuses on the size of the 
research community, collaboration features and research impact. Social network analysis is 
used to identify changes over time in the co-authorship networks in the field.  
 
1. Size of the research community: it is measured by the number of authors, institutions and 
papers in the field. Author names are normalised and linked to their institutional address 
according to an algorithm previously described in the literature (Costas and Bordons, 2007). 
Accordingly, two different measures are used: number of author occurrences (authorships) and 
                                                 
1 A preliminary version of this paper has been presented to the Science and Technology Indicators Conference, Montreal, Canada, September 5-8, 
2012 (Bordons et al., 2012). 
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number of different authors. For example, ten author occurrences may correspond to only two 
different authors with five publications each. 
 
2. Collaboration. Different aspects of collaboration are studied: 
 
a) Collaboration type. Publications are classified as belonging to one of the following three 
groups of papers: non collaborative papers (a single institution), national collaboration papers (at 
least two Spanish institutions), and international collaboration papers (at least one foreign 
address). Publications including both national and international collaboration are included in the 
international type. 
 
b) Collaboration scope, which refers to the size and the type of partners involved. 
 
The scope of national links is studied using the following indicators: 
 Size of links: it considers the number of partners included in the collaboration. 
Heterogeneity is assumed to grow as the number of partners involved increases. 
 Type of partner by institutional sector. The following institutional sectors are considered: 
university (UNIV), health sector (HOSP), companies, the Spanish National Research 
Council (CSIC)2 , non-profit organizations (NPO) and public research centres (including 
public administration) (PRC). We distinguish between single-sector and cross-sector 
publications. Cross-sector links may be considered as an indication of a higher degree of 
heterogeneity in the collaboration since institutional differences in missions, organisation 
and operation may exist. 
 
The scope of international links is analysed using the following indicators: 
 
 Size of links: collaboration between two (bilateral) or more countries (multilateral) is 
studied. Higher heterogeneity is assumed for multilateral collaboration. 
 Type of partner by R&D intensity: countries are classified in two classes according to 
their level of commitment with research and development activities as measured by their 
gross domestic expenditures in R&D as a percentage of their gross domestic product 
(%GERD/GDP) (source: World Bank). Those with a %GERD/GDP equal to or higher 
than the Spanish value are considered as high-level RD countries, while the remaining 
countries are deemed low-level RD countries. Data on R&D expenditure by country refer 
to 1999. The same reference was used throughout the period to make inter-period 
comparisons possible. If both a low and a high-level RD country are included in a given 
publication, then it is deemed to belong in the high-level RD class. 
 
c) Co-authorship networks. The structural network properties were analysed through the study of 
links between authors by means of PAJEK software (http://pajek.imfm.si/), which allows us to 
study the evolution of cohesiveness in networks over time.  
 
3. Research impact. For the study of research impact, two citation-based indicators normalised 
to the average world value are used following the methodology described by the CWTS in 
Leiden (Waltman et al., 2011). The use of citations as an indicator of research impact in the 
scientific community is widespread in the literature, although we should stay aware of its 
advantages and limitations (Moed, 2005). 
                                                 
2
 Although the CSIC belongs to the sector of public research centres, it has been considered separately under the assumption that collaboration 
between different CSIC centres involves less diversity than that between CSIC’s and other public research centres. 
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The field-normalised average journal impact (MNJS) is the mean citation rate of the journals in 
which Spanish scientists have published compared with the mean citation score of all papers 
published in the field. If MNJS is above 1, scientists are publishing in journals with a relatively 
high impact (high international visibility). The mean normalised citation score (MNCS) compares 
the average number of citations to the oeuvre of Spanish scientists with the field mean citation 
scores. Self-citations are excluded from these calculations. These indicators are calculated for 
two periods: 1998-2000 and 2006-2008. Citations with a 3-year citation window are used in the 
analysis. Accordingly, citations received in 1998, 1999 and 2000 are considered for papers 
published in 1998. 
 
The number of references is included as a proxy for the comprehensiveness of the research 
(McVeigh &Mann, 2009; González-Albo & Bordons, 2011; Costas et al., 2012) which contributes 
to the quality of publications and may attract a higher number of citations (Haslam et al., 2008). 
 
For the study of the applied/basic orientation of research we use the research level of 
publications, based on a classification of journals in four categories ranging from most-applied 
journals (level 1) to the most-basic journals (level 4). This was initially described by CHI (Noma, 
1986) and later updated by ipIQ. 
 
Differences in impact by collaborative type are analysed by means of statistical tests for non-
parametric variables (Kruskal-Wallis and Man-Whitney tests). The influence of network size and 
type of collaboration on the impact of research is studied through multiple regression analysis for 
categorical variables (SPSS, version 19).  
 
Results 
 
The scientific output of Spanish authors in Pharmacology and Pharmacy journals totalled 
1,971 publications for 1998-2000 and 2,858 for 2006-2008. These publications were 
studied to analyse changes in the number, diversity and scope of collaborative links and 
explore the relationship between collaboration and different aspects of research 
performance (productivity, impact).  
 
Trends in collaboration type and scope  
During the period under analysis the size of the scientific community has increased as measured 
both by the number of authors (increase of 63%) and by the number of active institutions 
(increase of 89%), both growing faster than the number of publications (45%) (Tables 1a and 
1b). Research becomes more collaborative, as shown by the increase in the average number of 
authors per publication, which points to larger research teams, as well as to the upward trend in 
the number of institutions per publication, an indication of growing extra-mural and institutional 
collaboration.  
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Table 1. Trends in scientific output, research community size and collaboration features in the 
field. 
 1998-2000 2006-2008 Growth (%) 
1a.Scientific output    
No. Publications (total count) 1,971 2,858 45 
No. Publications (fractional count) 1,689.59 2,334.95 38 
    
1b.Research community    
Individuals    
No. Author occurrences (authorships) 9,867 16,125 63 
No. Different authors (AUCEN
1
) 5,896 10,099 71 
    
Institutions    
No. total institutions (occurrences) 4,168 7,898 89 
     No. Spanish institutions 3,116 (75%) 5,491 (70%) 76 
     No. Foreign institutions 1,052 (25%) 2,407 (30%) 128 
    
Teams    
Authors/pub. (average) 5.01 5.64 13 
Institutions/pub. (average) 2.11 2.76 31 
    
1c.Collaboration pattern (institutions)    
No. Non-collab. Pub. (intramural) 847 (43%) 919 (32%) 9 
No. National collab. Pub. 621 (31%) 1,027 (36%) 65 
No. International collab. Pub. 503 (25%) 912 (32%) 81 
    
1d.National collaboration scope
2 
   
No. Pub. by number of partners    
    2 partners 408 (56%) 531(40%) 23 
    More than two partners 319 (44%) 807(60%) 134 
    
No. Pub. by sectors involved    
    Single-sector national collab. 338 (46%) 516 (39%) 53 
    Cross-sector national collab.  389 (54%) 822 (61%) 111 
    
1e.International collaboration scope    
No. Pub. by number of partners    
    Bilateral International collab. 392 (78%) 622 (68%) 59 
    Multilateral International collab.  111 (22%) 290 (32%) 161 
    
No. Pub. by RD intensity of partners
3 
   
    %R&D/GDP < Spain 87 (17%) 166 (18%) 91 
    %R&D/GDP >= Spain 413 (83%) 734 (82%) 78 
Notes: 
1 
Unique authors are identified and linked to their institutional address (AUCEN file). 
2 
Papers which present national and international collaboration simultaneously are included here. 
3
 %GERD/GDP not available for a few countries (10 publications excluded from related analyses). 
 
 
During the whole study period, the average number of authors per publication has increased 
from 5 to almost 6 (Table 1b). The greatest changes have been identified in publications with 4-5 
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authors, which altogether, include almost 40% of the total production in the first period and 
account for less than 30% in the second one, in which the percentage of publications with more 
than 6 authors shows un upward trend, especially for publications with 10 authors or more, up 
from 5% to 10%. For the first 3-year period (Figure 1a), the most frequent number of authors per 
publication is 4, while 6 authors is the predominating figure for the second period. Concerning 
institutions, the share of publications with 1 institution falls from 43% to 32%, while the 
percentage of publications with 4 institutions or more is up from 11% in the first period to 25% in 
the second one (Figure 1b).  
 
Interestingly, the average number of authors per publication remains stable over time if we 
control for the number of institutions (Figure 1c). This suggests that the intra-mural size of teams 
does not change over time while the rise observed in the number of authors per publication is 
mainly due to an increase in the number of institutions participating in publications. 
 
The number of internationally co-authored publications grows faster than that of nationally co-
authored papers (65% vs. 81%, Table 1c). Moreover, the scope of both national and 
international collaboration also widens over the period. A rise in heterogeneity is observed for 
national collaboration, since multi-institutional and cross-sector collaboration increase above 
average (134% and 111%, respectively; vs. 45% for the total field, Table 1d)3. With respect to 
international collaboration, it was present in 25% of the publications in the first period but rises to 
32% in the second. Moreover, international collaboration among three or more partners 
(multilateral) grows faster than that between two partners (bilateral), which actually shows a 
decline in percentage (from 78% in the first period to 68% in the second period) (Table 1e). 
Finally, it is interesting to note that collaboration with high-level RD countries remains quite 
stable over the years (around 82% of internationally co-authored papers) although it includes a 
growing share of papers written in collaboration between low and high-level RD countries (from 
5% to 12%) (Table 1e). Overall, these findings suggest that collaborative research has been 
conducted in larger and more heterogeneous networks in our second reference period. 
 
 
                                                 
3
 Special mention should be made of the rise in the share of co-authored papers between university and hospitals, which increases from 13% to 23% of 
university papers over time. 
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Figure 1. Changes over time in (a) the distribution of publications by number of authors per 
publication; (b) the distribution of publications by number of institutions per publication; (c) 
number of authors by number of institutions 
1a.                 1b 
 
1c 
 
 
Co-authorship network analysis 
 
The main features of the network of authors in the field are shown in Table 2. During the period 
under analysis 99% of all authors were connected to at least another author in each of the study 
periods and the size of the network expanded from 5,843 to 10,038 connected authors. 
Interestingly, a rise in network connections over time can be observed by means of different 
measures which are explained below. 
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Density, which represents the percentage of all possible connections among individuals, shrank 
slightly over the years, but this measure is not useful to analyse the evolution of network 
cohesiveness because it depends on the size of the network (density tends to diminish in larger 
networks because the number of possible links grows with the number of vertices). The average 
degree is a better measure of overall cohesion, because it does not depend on network size. 
The average degree centrality increases from 7.2 to 8.9. It measures the total number of authors 
with which a scientist wrote publications. It reflects the average compactness of the network of 
authors. The standard deviation informs us about the variability of this measure, which is higher 
in the second period.  
 
The longest distance among members in the network shows us the diameter of the network 
which falls from 28 to 24. Likewise, the average distance among authors falls from 11.4 to 8.7. 
This means that, in rough figures, any researcher is connected to any other researcher in the 
network through 8 other intermediate researchers in the second period. A decline has been 
observed from one period to another suggesting that the network is becoming more densely 
connected. 
  
With regard to the degree of integration we can analyse the components, which are groups of 
actors that are connected within their group but disconnected with other groups. We observe 
that the number of components rises from 518 to 696, and the main component connects 34% 
of the authors in the first period vs. 53% in the second one, reflecting a more cohesive network 
in the most recent period. 
 
The k-core is a maximal sub-network in which each vertex has at least a k degree within the 
sub-network. We can see that the core of the network increases from 27 in the first period to 34 
in the second, which again suggests a more interconnected network in the second period under 
study. 
 
The tendency of authors to form local clusters with other colleagues is measured through the 
clustering coefficient, which ranges from 0 to 1. This indicator remains stable for the two periods 
(0.8). 
 
 
Table 2. Main features of the Pharmacology & Pharmacy network in two three-year periods 
 
Pharmacology  (Total authors) 1998-2000 2006-2008 
No. Publications 1,971 2,858 
No. Authors (nodes) 5,896 10,099 
No. Edges (links) 21,292 44,706 
No. Connected nodes 5,843 (99.10%) 10,038 (99.40%) 
Density 0.0012252 0.0008768 
No. Connected components 518 696 
No. Authors in the main component (%) 2,002 (33.96%) 5,400 (53.47%) 
Average degree centrality 7.22 8.85 
SD degree (standard deviation) 5.63 7.39 
Average distance  11.36 8.71 
Diameter (longest distance) 28 24 
Clustering coefficient (average) 0.88 0.88 
Size k-core 27 34 
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Research performance 
 
a) Does collaboration contribute to increase the productivity of scientists? 
The number of publications shows a rate of increase below the one observed for the number of 
authorships (45% vs. 63%) (Table 1a and 1b), and the average productivity of scientists (defined 
as the number of authorships per unique researcher) falls from 1.67 to 1.60 articles per author. 
Therefore, the growth in production observed in the field is not due to an increase in the 
productivity of scientists, but to an important surge in the number of active scientists. The 
general distribution of authors by productivity level is quite similar for both periods. Around 70% 
of authors appear only once during each period, while only 1% has published 10 or more 
publications. A striking finding is the higher range of productivity values observed for the top 5% 
of authors with the highest productivity in the second period (1-65 vs. 1-22 in the first period), 
which suggest a productivity boost for the elite of most productive authors. 
 
b) Does collaboration contribute to increase the impact of research? 
The scientific papers of Spanish authors in Pharmacology and Pharmacy tends to be published 
in “better” journals (9% increase in MNJS) and to receive a higher number of citations (13% 
increase in MNCS) in the second period. However, both MNJS and MNCS values remain slightly 
below world average (Table 3). The rising trend in the average number of references per 
publication is consistent with the publication in higher impact factor journals, since a higher 
referencing density (average number of references per publication) has been described in this 
respect (Costas et al., 2012). Interestingly, the second period shows a bias in favour of clinical 
research when compared to the first period. The percentage of publications published in basic 
journals (levels 3 and 4) falls from 79% to 68%. 
 
Table 3. Trends in research performance 
 
 1998-2000 
Av (SD) 
2006-2008 
Av (SD) 
No. Citations/publication 3.75 (5.55) 6.15 (8.22) 
No. Citations/publication (-sc)* 2.59 (4.60) 4.68 (6.97) 
MNJS 0.88 (0.61) 0.96 (0.59) 
MNCS 0.80 (1.29) 0.91(1.21) 
No. References/publication 31.75 (28.54) 48.31 (45.25) 
Level 2.90 (0.67) 2.74 (0.72) 
Note: average data (standard deviation). Significant differences between first and second period for all variables (p<0.001). *(-sc) = 
self-citations removed 
 
The influence of the number of authors, the number of institutions and the type of collaboration 
on the impact of publications is analysed. Figure 2 shows that single-authored publications 
obtain the lowest impact figures since these papers are published in journals with the lowest 
MNJS values and receive the lowest number of citations (lower MNCS). As the number of 
authors goes up, MNJS values also tend to do so and the highest values correspond to papers 
with at least 8 authors. The same trend is observed with respect to citations, but publications 
with at least 8 authors present a higher increase in the rate of citations (almost 25% above 
average). In addition, Figure 3 reveals an upward trend in impact as the number of involved 
institutions grows. Comparing the two periods, publications tend to present higher impact values 
in the second period irrespective of the number of authors (Figure 2) or institutions (Figure 3). It 
is interesting to note that this pattern of impact growth in step with the number of authors and 
institutions is also observed when nationally and internationally co-authored papers are 
analysed separately (Appendix 1). 
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Figure 2. Average MNJS (left) and MNCS (right) by co-authorship rate for the two periods under 
study 
 
 
 
 
 
Figure 3. Average MNJS (left) and MNCS (right) by number of institutions for the two periods 
under study 
 
 
 
Publications where 2 or more institutions are involved are published in journals with higher 
MNJS values than those produced by a single institution, while international collaboration 
provides an extra drive compared to national collaboration, although differences are statistically 
significant only in the second period. As for the analysis of citations, the lowest MNCS values 
also correspond to publications produced by a single institution, while publications in 
international collaboration show higher MNCS values than those with only national partners 
(Table 4). 
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The higher impact of internationally co-authored publications is strongly determined by 
multilateral collaboration, since this type of collaboration obtains higher MNCS and MNJS values 
than bilateral collaboration for both periods (p<0.01). Besides, multilateral papers show a lower 
basic research level than bilateral ones for both periods (p<0.01)4. 
 
Table 4. Descriptive statistics for MNJS and MNCS by collaborative types and by period 
 MNJS MNCS 
1998-2000 
Av (SD) 
2006-2008 
Av (SD) 
Increase 
 
1998-2000 
Av (SD) 
2006-2008 
Av (SD) 
Increase 
 
1.No collab. 0.80 (0.57) 0.79 (0.54) 0.99 0.65 (1.05) 0.74 (1.04) 1.14 
2. National collab. 0.94 (0.62) 0.99 (0.49) 1.05 0.79 (1.27) 0.87 (1.00) 1.10 
3. International collab. 0.95 (0.65) 1.10 (0.70) 1.16 1.07 (1.59) 1.12 (1.51) 1.05 
    3.1.Low RD countries 0.64 (0.47) 0.93 (0.49) 1.50 0.48 (0.62) 0.85 (0.84) 1.83 
    3.2.High RD countries 1.01 (0.66) 1.14 (0.73) 1.05 1.20 (1.70) 1.19 (1.62) 1.03 
Total 0.88 (0.61) 0.96 (0.59) 1.09 0.80 (1.29) 0.91 (1.21) 1.13 
Note: 
a) 3-collaborative types (1, 2, 3): significant differences in MNJS and MNCS by collaborative types (p<0.001). Significant differences between all 
collaborative types except for MNJS of national vs. international publications in the first period. 
b) 4-collaborative types (1, 2, 3.1, 3.2): significant differences in MNJS and MNCS by collaborative types.  MNJS: significant differences between all 
collaborative types, except national vs. international coll. with high-level RD countries (in first period). MNCS: significant differences between all 
collaborative types, except national vs. international coll. with low-level RD countries (both periods). 
 
 
c) Is the level of development of the partners of research systems an influential factor on the 
impact of final research? Our data suggest that this is indeed the case. Collaboration with high-
level RD countries seems to be the most beneficial for Spanish partners in terms of impact 
(Table 4). 
 
Figure 4 enables us to compare MNJS and MNCS values by collaboration type for the two 
reference periods. As far as MNJS values are concerned (graph on the left), it is worthwhile 
mentioning that collaboration with low-level RD countries attains the lowest values in the first 
period, but the gap with the remaining collaborative types is reduced in the second one, where 
its values are similar to those obtained by national collaboration and slightly outperform the 
impact of publications without collaboration. If field-normalised citations are considered (graph 
on the right), the same trend is observed. The citation rates of publications co-authored with 
more intensive RD countries is around 20% above world average for both periods. It seems that 
the extra drive derived from collaboration with high-level RD partners compared to the rest of 
publications is higher in MNCS than in MNJS values. On the other hand, it is noteworthy that 
publications in collaboration with high-level RD countries are over-represented among most cited 
publications, since one third of most cited papers are from high-level RD countries although they 
only account for 20% of total publications.  
                                                 
4
 Average research level: 2.74 for multilateral vs. 2.95 for bilateral collaboration in the first period; 2.57 for multilateral vs. 2.82 for bilateral collaboration 
in the second period. 
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Figure 4. Average MNJS (left) and MNCS (right) by 4 collaboration types for the two reference 
periods 
 
 
 
 
Publications co-authored with high-level RD countries tend to be published in more visible 
journals, receive on average a higher number of citations and are more likely to be among most 
cited papers.  
 
d) Do all institutional sectors benefit from collaboration? The analysis by institutional sector 
shows that the impact of research tends to grow as the heterogeneity of collaboration rises (from 
single-institution publications to nationally co-authored ones and from national to international 
collaboration) for most sectors. Data for the 2006-2008 period shown in Figure 5 reveal that 
almost all sectors tend to present MNJS and MNCS values above 1 for internationally co-
authored publications. National collaboration leads to MNJS values above world average in a 
few sectors, but only international collaboration is associated with MNCS value above world 
average. 
 
Which sector benefits most from international collaboration? Focusing on the 2006-2008 period, 
internationally co-authored publications of companies get impact values at least 30% higher than 
average company publications (both MNJS and MNCS values); and the same applies to hospital 
publications (in this case only MNCS values) (Figure 5).  
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Figure 5. MNJS and MNCS by institutional sector and collaboration type (2006-2008) 
MNJS, 2006-2008
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MNCS, 2006-2008
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Note: The number of publications by institutional sector is as follows: University=1,567; Hospitals=1,060; Companies=413; Non-profit organizations 
(NPO)=340; CSIC=296; Public research centres (PRC)= 133 articles. 
 
 
Considering the set of nationally co-authored publications, those involving partners from different 
institutional sectors show higher MNJS (p<0.001) and MNCS values (p<0.05) than those with 
partners from the same sector. This is observed for the first period, while no differences appear 
for the second. Since cross-sector collaboration also involves, on average, a higher number of 
institutions, the analysis is also conducted controlling for the last variable. In this case, the 
differences are reduced to publications written by 2 institutions in the first period, where higher 
impact (MNJS and MNCS) is observed for cross-sector partnership (p<0.01). 
 
e) Influence of network size and type of collaboration on the impact of publications. Categorical 
regression analysis is used to explore the influence of different variables on the impact of 
research. This method is preferred to the conventional regression analysis because of the 
skewed distribution of the variables and the fact that we have some nominal variables 
(collaboration type). Categorical regression may introduce numerical, nominal and ordinal 
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variables which are effectively transformed into interval variables (using SPSS). Multiple 
regression analysis is applied to the transformed variables. The number of institutions was 
removed from the analysis due to collinearity problems.  
 
MNJS and MNCS are the dependent variables in two different analyses (Tables 5 and 6). For 
each variable, two different models are developed and applied to both reference periods. 
Independent variables include the number of authors, the type of collaboration (4 categories, 
international collaboration is disaggregated by partner RD intensity), and the number of 
references.  
 
Analysis I: MNJS as the dependent variable (Table 5). For the two periods the three variables 
mentioned above are significant and show a positive influence over MNJS (positive beta 
coefficients). In the first period, the most influential variable is the number of references (highest 
beta value), followed by the number of authors and the type of collaboration. As observed in 
Table 5b, the system quantifies the “collaboration type” categorical variable into a numerical 
one, which shows a rising trend from “International collaboration with low-level RD countries” 
(lowest value), through “No collaboration” and “National collaboration”, to “International 
collaboration with higher-level RD countries” (highest value). It is interesting to point out that “No 
collaboration” and “National collaboration” return very similar values, while “Int.Col.with low-level 
RD countries” is well below such values and “Int.Col.with high RD countries” largely exceeds 
them. Accordingly, the lowest MNJS corresponds to collaboration with low-level RD partners, 
while the highest is found for high-level RD investing partners. With regard to the second period, 
the number of authors is the most influential variable. Here the type of collaboration is 
transformed into a numerical variable showing a rising trend from “No collaboration” (lowest 
value) to “International collaboration with high-level RD countries” (highest value) (Table 5b). A 
striking finding is that low-level RD countries are not associated with lowest MNJS values any 
longer.  
 
Analysis II: MNCS as the dependent variable (Table 6). The most influential variable is MNJS, 
which means that publications in high impact factor journals are more likely to receive high 
citation rates. The number of references per publication is the second most influential variable 
for both periods. The type of collaboration is more influential than the number of authors for the 
first period, while both variables show very similar beta coefficients for the second period. 
 
Both analyses indicate that there is a positive correlation between impact and some indicators of 
collaboration such as the number of authors and the type of collaboration. The number of 
authors is more influential than the collaboration type for explaining MNJS, while the opposite 
trend is observed for MNCS. In spite of the existing correlation, we cannot draw inferences about 
causality due to the low values of R2. 
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Table 5. Categorical regression analysis to explain MNJS  
 
5a. Categorical regression analysis 
 
MNJS 
Standardised coefficients  
F 
 
Sig.  
Beta 
Bootstrap (1000) 
Estimate of  
Std.Error 
1998-2000 
No. References 0.277 0.024 132.137 0.000 
No. Authors 0.164 0.028 35.250 0.000 
Coll_type4c_i2 0.101 0.027 13.535 0.000 
Corrected R
2
=0.132 
2006-2008     
No. References 0.136 0.023 35.044 0.000 
No. Authors 0.235 0.022 114.048 0.000 
Coll_type4c_i2 0.143 0.021 47.081 0.000 
Corrected R
2
=0.114 
 
5b. Transformation of the “collaboration type” variable 
Category Frequency Quantification 
1998-2000 
Int.collab. high RD countries 413 1.352 
National collaboration 620 0.071 
No collaboration 842 -0.348 
Int.collab.low RD countries 87 -3.559 
2006-2008 
Int.collab. high RD countries 732 1.192 
National collaboration 1,025 0.350 
Int.collab. low RD countries 166 -0.014 
No collaboration 908 -1.354 
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Table 6. Categorical regression analysis to explain MNCS 
 
6a. Categorical regression analysis 
 
MNCS 
Standardised coefficients  
F 
 
Sig.  
Beta 
Bootstrap(1000) 
Estimate of 
Std.Error 
1998-2000 
No. References 0.112 0.021 28.708 0.000 
No. Authors 0.082 0.033 5.994 0.003 
Coll_type4c_i2 0.101 0.022 21.532 0.000 
MNJS 0.447 0.021 440.734 0.000 
Corrected R
2
=0.261     
2006-2008 
No. References 0.106 0.016 42.097 0.000 
No. Authors 0.045 0.021 4.641 0.003 
Coll_type4c_i2 0.051 0.028 3.247 0.011 
MNJS 0.422 0.016 676.396 0.000 
Corrected R
2
=0.204     
 
 
 
6b. Transformation of the “collaboration type” variable 
Category Frequency Quantification 
1998-2000 
Int.collab. high RD countries 413 1.899 
No collaboration 842 -0.305 
Int. Collab. low RD countries 87 -0.718 
National collaboration 620 -0.750 
2006-2008 
Int.collab. high RD countries 732 1.366 
Int.collab. low RD countries 166 1.336 
No collaboration 908 -0.150 
National collaboration 1,025 -1.059 
 
 
Figure 6 shows the MNJS and MNCS variables by collaboration type and number of authors for 
the two periods. The greatest impact corresponds to collaboration with high-level RD countries in 
all four graphs. In general terms, we can see a slightly upward trend of impact as the number of 
authors grows, especially for publications written by a single institution or by several domestic 
ones. Attention should be paid to the fact that the greatest impact (either for MNJS or MNCS) is 
obtained for publications with 8 or more authors. In fact, for publications with a single institution 
or several domestic ones, impact above world average is only obtained if the number of authors 
is 8 or more. Internationally co-authored publications tend to show the highest impact values in 
all cases, but this impact is similar to that of the other collaborative types in terms of MNJS while 
it is well above that in the case of MNCS. This is consistent with the stronger influence of the 
collaborative type on MNCS values compared to MNJS values shown in the categorical 
regression analysis. 
 
 
 18 
Figure 6. Impact by number of authors, type of collaboration and period. 
 
 
 
Note: 26 single-authored publications (0.5% of total papers) present more than one institutional address. These records were kept in the collaborative 
categories under the assumption that they were more heterogeneous than single-authored single-address papers since their authors may benefit from a 
wider range of scientific influences at their different institutional addresses. 
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Discussion 
 
Our data show the growing role of collaboration in the Pharmacology and Pharmacy field in 
Spain as evidenced by the upward trend in the number of authors, institutions and countries per 
paper. This is consistent with the trends described for world science in general (Gazni et al., 
2011) and for Spanish science in particular (Gómez et al., 2010). In Gazni’s study on world 
scientific publications in WoS during 2000-2009, Pharmacology and Toxicology is ranked 6th out 
of 22 areas according to the multi-authored publication rate, 12th by its multi-institutional rate and 
19th by its international publication rate. An upward trend in collaboration over the years was 
observed in all cases. These data illustrate that research in this area is conducted by research 
teams (high rate of multi-authored publications) with a remarkable level of national collaboration 
and a smaller role of international links. Our data concerning Spanish research show higher 
rates of collaboration than those described by Gazni for the world output (around 15 percentage 
points higher), but it is well established that inter-country differences do exist due to different 
factors such as country size, rate of scientific development, and political or economic reasons 
(Glanzel and Schubert, 2004). The growth rate of collaborative papers in the Pharmacology and 
Pharmacy field in Spain is similar to the growth rate described for Biomedicine in the country (an 
increase of 71% vs. 74% in collaborative publications, respectively), but below the overall 
country average (an increase of 91%) since the highest increase has been described for 
traditionally low collaborative fields within the Social Sciences and Humanities (an increase of 
around 200%) (Bordons et al., 2012). 
 
The description of co-authorship links by means of a social network analysis provides us with 
interesting information to analyse changes in the collaborative structure of this field. Specifically, 
a larger (longer diameter) and more integrated and cohesive network of authors (higher average 
degree centrality, shorter average distance among authors and higher share of authors in the 
main component) is observed for our second period of reference. In this paper, the share of 
authors in the main component is lower than in other studies (see for example, Newman 2001, 
where the discipline with the smallest main component contained 57% of authors), but it is 
probably due to our journal-based delimitation of the field. In any case, the important issue is the 
growing rate observed for this indicator over the years (from 34% to 53%) suggesting a fairly 
general increase of collaboration in the field. Overall, the growing interconnection among 
authors might enhance the transmission of knowledge in the scientific community as well as 
contribute to carry out research more effectively.  
 
Heterogeneity of collaboration 
Collaboration practices evolve towards greater heterogeneity. On the one hand, as the number 
of contributing authors and institutions grows, so does the likelihood of finding more diverse 
partners in research activities. On the other hand, not only collaboration involves a greater 
number of institutions in recent years, but also there is a rise in collaboration across institutional 
sectors and countries which grows faster than collaboration within a given sector or within the 
same country and constitutes a potential source of diversity. 
  
The upward trend in the number of authors per publication points to a larger size of research 
teams. However, if we control for the number of institutions, very small differences in the number 
of authors per publication are found between the first and the second period under analysis. This 
means that the rise in extra-mural collaboration is the main cause responsible for the upward 
trend in the number of authors per publication. Researchers tend to be ever more open to 
establish links with other teams both from their own country and from abroad, thus probably 
facilitating access to infrastructures and complementary knowledge to an extent that would not 
be reached by merely expanding the size of in-house. 
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Our study reveals an important surge in cross-sector publications and, in particular, joint 
hospital-university publications. This is especially relevant since, in as far as biomedicine is 
concerned, it is deemed to be an indicator of the development of translational research, i.e. to 
translate basic research into medical practice, bridging the gap between basic and clinical 
research. A bi-directional flow is supposed to exist between basic research settings and clinical 
ones and such flow may lead to mutual learning, creation of new knowledge and transfer of this 
knowledge into practice (Lander, 2012). These cross-sectoral links may prove crucial in 
pharmacological research for the development and trial of new drugs and their introduction in 
the market. 
 
With regard to international links, two different types of partnership are considered: bilateral and 
multilateral collaboration. Bilateral collaboration is the prevailing type in both reference periods, 
but multilateral collaboration gains ground over time (from 22% to 32%). This ascending trend, 
which has also been identified in other studies dealing with science in Latin American and 
European countries (Gómez et al., 1999; Glanzel and Lange, 2002; Mattsson et al., 2010), 
points to a trend of increasing involvement in large global research projects (Gorráiz et al., 2012; 
Basu and Vinu-Kumar, 2000). On the other hand, Spanish authors collaborate mainly with high-
level RD countries (more than 2/3 of internationally co-authored publications), but the 
percentage of publications including both high and low-level RD countries has more than 
doubled (from 5% to 12%). Overall, these findings point to the existence of more heterogeneous 
networks of countries in the last period under study.  
 
Collaboration and scientific productivity 
The size of scientific output has expanded by about 45% from 1998-2000 to 2006-2008, which is 
a rate very similar to that described for all fields in Spain for the same period. Our data suggest 
that this upward trend in production is due to a growing number of active authors rather than to 
an increase of author productivity, since the average productivity of authors declined slightly 
over time and the number of authors grew faster than the number of publications (63% vs. 45%). 
The possibility that complexity of research objectives targeted by researchers has risen over 
time, thus requiring the involvement of larger and more multidisciplinary teams could be one 
underlying reason to explain why the surge in collaboration is not associated with a boost in 
individual productivity. In our study, only the productivity of most productive authors tends to rise, 
which suggests that this elite of very prolific authors may benefit most from collaboration (Beaver 
and Rosen, 1979), but further research is needed to confirm this statement. Notwithstanding, the 
fact that only publications in Pharmacology and Pharmacy journals are considered in this study 
and pharmacologists also publish in journals on other subfields (Bordons and Barrigón, 1992) 
should not be ignored; therefore, the pending question to be solved would be to determine 
whether growing collaboration has lead to more publications in other subfields and dealing with 
more complex scientific questions. 
 
Collaboration and impact of research  
Over the years, scientific output tends to be published in “better” journals (increase of 9% in 
MNJS), presents a higher number of references per publication and receives a higher number of 
citations/publication normalised to world average (increase of 13% in MNCS), altogether 
suggesting an ascending trend in the scientific influence of  Spanish pharmacological research.  
 
Is this increment also related with the rise in collaboration? Our data suggest that this is the 
case, since MNJS and MNCS values tend to grow in step with the number of authors and, to a 
minor extent, with the number of institutions. In fact, the highest impact is observed for 
publications with more than 7 authors or more than 4 institutions. A positive relationship between 
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the number of authors, the number of institutions and the research impact of publications has 
also been observed in other studies (see for example, Gazni and Didegah, 2011). The 
underlying reason suggested in the literature is the higher quality of research developed in the 
framework of larger teams which complement each other in their specialisation profile and 
available skills, and which are able to produce more original, consistent and comprehensive 
research (Katz and Martin, 1997). The fact that higher citation rates may be due to a higher 
number of self-citations has also been suggested (Glänzel and Thijs, 2004). For the purposes of 
our study, the influence of self-citations is to be discarded since they were removed from the 
calculation of citation rates. However, it is true that, for publications with a higher number of 
authors and institutions, the dissemination of research through personal networks may 
contribute to favour the visibility of papers and their likelihood to be cited (Goldfinch et al., 2003). 
However, the fact that multi-authored publications not only tend to receive more citations but 
also to be published in higher impact journals supports the positive influence of collaboration on 
final research.  
 
If the type of collaboration is taken into account, we observe that publications in national 
collaboration tend to be published in better journals and receive a higher number of citations 
than those written by a single institution but lower than internationally co-authored publications. 
Both national and international collaboration contribute to obtain MNJS values above country 
average, but only internationally co-authored publications attain citation rates above world 
average. This is consistent with the results of Thijs and Glänzel (2010) concerning the scientific 
output of 15 EU countries in 2003, who observed that extra-mural collaboration boosted citation 
rates and international collaboration added to this effect, especially in the medical fields. 
Moreover, the higher impact of multilateral papers compared to bilateral ones observed in our 
study is consistent with the findings of Glänzel and Lange (2002) in a study on worldwide 
scientific output during 1995-1996 (SCI) where higher observed and expected citation rates 
were described for multinational biomedical papers. Differences in the aims and organisational 
factors underlying both types of collaboration may contribute to explain these results. Bilateral 
collaboration is supposed to reflect national research portfolios and it is more likely to be based 
on individual initiative (Gorráiz et al., 2012; Basu and Vinu-Kumar, 2000), while multilateral 
collaboration comprises research with a more global orientation and may be the result of 
institutional or international initiatives. As far as pharmacological research in Spain is concerned, 
bilateral collaboration shows a more basic research level and higher relative involvement of 
academic scientists (university and CSIC), while multilateral collaboration shows a more applied 
orientation and higher relative activity of hospitals and NPOs (Bordons et al., 2012). This 
category of publications probably includes clinical trials, which frequently involve many 
institutions and countries in a given paper and tend to receive more citations than conventional 
papers in Biomedicine (see for example, Kostoff, 2007; García-Romero et al., 2009).  
 
It seems that research impact tends to grow with the type of collaboration and the number of 
authors, but which of these variables is more influential? Our study shows that the number of 
authors is more influential than the type of collaboration on the MNJS indicator, while a stronger 
influence of the type of collaboration is observed for MNCS. This is partly explained by the high 
MNCS values of papers in collaboration with high-level RD countries (20% above world average 
with small differences by the number of authors), a long way from the impact of the remaining 
collaborative categories, especially for the first period. As a consequence, establishing links with 
foreign partners is a useful collaborative strategy to increase the citation rate of publications. 
However, it is interesting to note that expanding the size of the teams, even at local or national 
level, is also positively associated with the impact of research, especially in terms of MNJS. 
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The fact that the impact of nationally co-authored papers also tends to grow with the number of 
authors and the number of institutions is a relevant finding which partially contradicts the results 
of Goldfinch concerning the scientific output of New Zealand Crown Research Institutes 
(Goldfinch et al., 2003) where higher levels of co-publications with domestic institutions not only 
did not result in an increase of citation rates, but reduced them. According to Goldfinch, national 
collaboration in peripheral countries may improve the quality of research but not its visibility and 
resulting citation rates due to the limited size of national social networks. In the case of Spanish 
pharmacological research, increasing the number of authors in domestic papers seems to be 
positive in terms of both publication journals and citation rates. However, it is interesting to point 
out that national collaboration shows a stronger positive effect on MNJS values than on MNCS 
values, which could be partly explained by Goldfinch’s thesis on the limited size of national 
networks. The higher visibility and dissemination among the world scientific community of 
internationally co-authored papers and the presumably global interest of a research topic which 
is addressed collectively among scientists from different countries are factors that -apart from 
the intrinsic quality of research- may contribute to explain their higher citation rates. 
 
An interesting finding of this study is that a positive relationship of collaboration, and especially 
of international collaboration, with the impact of publications is observed for all the different 
institutional sectors within the country. National collaboration leads to MNJS values above world 
average in a few sectors, but only international collaboration is associated with MNCS values 
above world average. The greatest benefit of international collaboration is observed for 
companies, which increase their MNJS and MNCS values by 33% and 55%, respectively, 
compared to the average values of impact in the sector. This sector shows the lowest overall 
impact in both periods, which supports the idea that the “weakest” partners (in terms of impact) 
are the ones who could benefit the most from collaboration (Bordons et al., 1993; van Leeuwen 
& Tijssen, 2007).  
 
The higher impact of cross-sector collaboration as compared with that developed within a given 
sector was observed only for 2-institution publications and in the first period. This finding 
supports only partially our hypothesis of growing impact for the more heterogeneous research 
developed in the framework of cross-sector publications. A possible explanation is that for higher 
co-institutional levels the number of institutions is a stronger source of diversity than the variety 
of institutional sectors. However, a more plausible reason is that the identity of the sectors 
involved other matters, since there are inter-sector differences in impact of research and 
collaboration with the most influential sectors (in terms of impact) might be especially positive for 
the less influential ones, as has been observed for companies. The detailed study of all such 
interconnections is beyond the objectives of this paper but it is an interesting issue for future 
analysis. A limitation of the cross-sector collaboration indicator is that it does not take into 
account the activity of a number of corporations or networks of institutions (for example, “CIBER” 
5, networks of research centres in biomedicine) which are trans-sectoral according to their 
composition but are included in our study in the NPO sector class on the basis of their non-profit 
aims.  
 
Spanish authors collaborate mainly with high-level RD countries and this type of collaboration 
seems to be advantageous for Spain in terms of scientific impact. However, it is interesting to 
observe that the impact of the collaboration with low-level RD countries tends to grow over time 
in terms of both impact of publication journals and citation rates, thus indicating that the 
collaboration with these low-level RD countries has been optimised over the years. It may 
indicate that Spanish scientists have made a more careful choice of partners during our last 
                                                 
5
 “Centros de investigación biomédica en red”(CIBER), created by the Spanish government to achieve a critical mass of researchers by fields and 
beyond institutional boundaries to succeed in obtaining excellence in research.. 
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reference period, but also that both Spanish and foreign teams are taking advantage of the 
learning experience derived from collaboration over the years, thus suggesting a kind of 
“beneficial investment” effect of prolonged collaboration. Moreover, it should be noted that while 
the share of Spanish publications including only low-level RD countries remains stable 
throughout the period, the share of multilateral publications written by both low and high-level 
RD countries shows an upward trend. This can be understood in the context of the increasing 
globalization of research (Tijssen et al., 2012), in general terms, and of the growing role of 
multilateral projects in pharmacological research, in particular, associated to the development of 
multi-country clinical trials. Moreover, deliberate government policies may support international 
collaboration as a method to foster regional cohesion and building scientific capacity in the least 
advanced countries (Mattson et al., 2010).  
 
All in all, our results show evidence of changes in the collaborative practices of Spanish 
scientists in the pharmacological field during the period under study which lead to the extended 
presence and heterogeneity of collaboration and is associated to a rising trend in research 
impact. A large number of authors and institutions, and the presence of international 
collaboration, in particular with high-level RD countries, are strategic factors which contribute to 
optimise the impact of Spanish publications in the field. Although the growing citation rates of 
collaborative papers might be enhanced by their access to larger social networks and related 
higher visibility, the fact that they are also published in higher impact factor journals points to a 
genuine improvement of research quality for collaborative papers. From a science policy 
perspective, it should be noted that promoting more heterogeneous collaboration (e.g. 
multilateral, cross-sector) probably needs more external stimulus than just establishing more 
simple links (e.g. bilateral, intra-sector) which are more easily developed by scientists on their 
own. The study of the “heterogeneity” of collaboration is addressed in this paper considering the 
collaboration type and the size of links, and assuming higher heterogeneity as the size of the 
links expands. The development of specific indicators to also measure “diversity” between 
partners remains our next objective to extend and deepen the study of the role of heterogeneity 
in research collaboration. 
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Appendix 1. Descriptive statistics for MNJS and MNCS by collaborative type, number of authors, 
number of institutions and period 
 
 1998-2000 2006-08 
MNJS MNCS MNJS MNCS 
National collaboration 
1 author 0.23(0.11) 0.01(0.03) 0.76(0.50) 0.50(0.56) 
2-3 authors 0.81(0.59) 0.52(0.64) 0.80(0.55) 0.65(0.79) 
4-5 authors 0.93(0.60) 0.72(1.19) 0.98(0.47) 0.87(0.99) 
6-7 authors 0.96(0.65) 0.88(1.34) 0.95(0.48) 0.83(1.00) 
>7 authors 1.04(0.64) 1.00(1.59) 1.17(0.45) 1.04(1.10) 
     
2 institutions 0.89(0.61) 0.66(0.89) 0.96(0.50) 0.83(1.04) 
3 institutions 1.00(0.63) 0.84(1.52) 0.98(0.48) 0.88(0.94) 
>3 institutions 1.08(0.65) 1.49(2.16) 1.07(0.48) 0.93(0.97) 
     
International collaboration 
1 author 0.78 (-) 0.73 (-) 0.22(0.02) 0.19(0.32) 
2-3 authors 0.72(0.51) 0.94(1.53) 1.08(0.66) 1.18(1.72) 
4-5 authors 0.95(0.64) 0.99(1.44) 1.03(0.49) 1.03(1.47) 
6-7 authors 0.93(0.63) 0.82(1.13) 1.04(0.51) 0.97(1.06) 
>7 authors 1.08(0.72) 1.53(2.12) 1.22(0.92) 1.31(1.76) 
     
2 institutions 0.94(0.61) 0.92(1.22) 1.05(0.57)
ns 
1.17(1.65)
ns 
3 institutions 0.84(0.62) 0.94(1.52) 1.06(0.52)
ns 
0.98(1.23)
ns 
>3 institutions 1.07(0.71) 1.40(2.02) 1.15(0.83)
ns 
1.17(1.56)
ns 
Note: average values (standard deviation) 
Significant differences in MNJS and MNCS by number of authors and number of institutions in all cases (p<0.05) except in those 
marked with “ns”. 
 
